𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TRAIL Is Associated with Impaired Regulation of CD4+CD25−T Cells by Regulatory T Cells in Patients with Rheumatoid Arthritis

✍ Scribed by Hong Xiao; Shun Wang; RunSheng Miao; WuSheng Kan

Publisher
Springer
Year
2011
Tongue
English
Weight
696 KB
Volume
31
Category
Article
ISSN
0271-9142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD4+CD25+ regulatory T cells in patients
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies : Possible involvement of regulatory T cells in disease progression
✍ Tetsuro Sasada; Motohide Kimura; Yuka Yoshida; Michiyuki Kanai; Arimichi Takabay 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract ## BACKGROUND Active suppression by CD4^+^CD25^+^ regulatory T cells plays an important role in the down‐regulation of the response of T cells to foreign and self antigens. Experimental tumor models in mice revealed that regulatory T cells inhibit antitumor immune responses. The purpos

Proinflammatory mediator–induced reversa
Proinflammatory mediator–induced reversal of CD4+,CD25+ regulatory T cell–mediated suppression in rheumatoid arthritis
✍ Jocea M. R. van Amelsfort; Joel A. G. van Roon; Madelon Noordegraaf; Kim M. G. J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract ## Objective We previously demonstrated that CD4+,CD25+ regulatory T (Treg) cells are present in increased numbers in the synovial fluid (SF) of rheumatoid arthritis (RA) patients and display enhanced suppressive activity as compared with their peripheral blood (PB) counterparts. Despi

Elevated frequencies of CD4+CD25+CD127lo
Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
✍ Zhang Shenghui; Han Yixiang; Wu Jianbo; Yu Kang; Bi Laixi; Zhuang Yan; Xu Xi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 779 KB

## Abstract Regulatory T cells (Treg) mediate amelioration of disease and immune homeostasis by inhibiting immune activation and maintaining peripheral immune tolerance. The suppressive mechanisms and clinical significance of Treg have not been completely elucidated in patients with acute myeloid l